BPTHBio-Path Holdings, Inc.

About Bio-Path Holdings, Inc. (BPTH)

Bio-Path Holdings, Inc. (BPTH) is a Biotechnology company headquartered in Bellaire, TX, United States whose shares trade over-the-counter on the OTCQB tier.

Bio-Path is a biotechnology company leveraging its proprietary DNAbilize liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs.

Products and services

We are a clinical and preclinical stage oncology and obesity-focused RNAi nanoparticle drug development company utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. Our drug delivery and antisense technology, called DNAbilize®, is a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction by the body’s enzymes when circulating in vivo, incorporated inside of a lipid bilayer having neutral charge. We believe this combination allows for high efficiency loading of antisense DNA into non-toxic, cell-membrane-like structures for delivery of the antisense drug substance into cells. In vivo, the DNAbilize® delivered antisense drug substances are systemically distributed throughout the body to allow for reduction or elimination of target proteins in blood diseases and solid tumors. Through testing in numerous animal studies and dosing in clinical trials, our DNAbilize® drug candidates have demonstrated an excellent safety profile. DNAbilize® is a registered trademark of the Company.

BPTH key facts

Ticker symbol

BPTH

Market tier

OTCQB

Sector

Healthcare

Industry

Biotechnology

Headquarters

Bellaire, TX, United States

Country of incorporation

US

Year of incorporation

2007

Employees

10

Estimated market cap

$1.29M (as of Apr 9, 2025)

Shares outstanding

8,308,007

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Bio-Path Holdings, Inc. leadership

• Peter Nielsen — CEO, CFO, COO
• Anthony Price — Vice President
• William R. Rohrlich, II — Legal Counsel

Explore more: Biotechnology stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with B